Japan Lifeline Co (JP:7575) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Japan Lifeline Co. has entered into a five-year exclusive distribution agreement with Terumo Corporation for the sales of its radiofrequency ablation system, arfa, used for liver cancer treatment. This strategic partnership, starting in April 2025, aims to bolster Japan Lifeline’s market presence and achieve significant sales growth in the gastrointestinal field by 2028. The deal is expected to have a minor impact on Japan Lifeline’s business performance.
For further insights into JP:7575 stock, check out TipRanks’ Stock Analysis page.